The relationship of Vascular endothelial growth factor gene polymorphisms and clinical outcome in advanced gastric cancer patients treated with FOLFOX: VEGF polymorphism in gastric cancer
Authors:
- Sung Yong OhSung Yong Oh
- Hyuk-Chan KwonHKHyuk-Chan Kwon
- Sung Hyun KimSKSung Hyun Kim
- Suee LeeSLSuee Lee
- Ji Hyun LeeJLJi Hyun Lee
- Jung-Ah HwangJHJung-Ah Hwang
- Seung Hyun HongSHSeung Hyun Hong
- Christian A GravesCGChristian A Graves
- Kevin CamphausenKevin Camphausen
- Hyo-Jin KimHKHyo-Jin Kim
- Yeon-Su LeeYLYeon-Su Lee
Open Access
- 1 February 2013
- journal article
- Published by Springer Nature in BMC Cancer
- Vol. 13 (1) , 43
Abstract
The aim of this study is to evaluate the associations between vascular endothelial growth factor (VEGF) Single-nucleotide polymorphisms (SNPs) and clinical outcome in advanced gastric cancer patients treated with oxaliplatin, 5-fluorouracil, and leucovorin (FOLFOX).Keywords
This publication has 31 references indexed in Scilit:
- Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2008Cancer Research and Treatment, 2011
- VEGF −460T → C polymorphism and its association with VEGF expression and outcome to FOLFOX-4 treatment in patients with colorectal carcinomaThe Pharmacogenomics Journal, 2010
- Oxaliplatin, 5-fluorouracil and Leucovorin (FOLFOX-4) Combination Chemotherapy as a Salvage Treatment in Advanced Gastric CancerCancer Research and Treatment, 2010
- The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumorsMolecular Cancer Therapeutics, 2009
- Polymorphisms and Clinical Outcome in Recurrent Ovarian Cancer Treated with Cyclophosphamide and BevacizumabClinical Cancer Research, 2008
- Association of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-2 Genetic Polymorphisms With Outcome in a Trial of Paclitaxel Compared With Paclitaxel Plus Bevacizumab in Advanced Breast Cancer: ECOG 2100Journal of Clinical Oncology, 2008
- Association of Vascular Endothelial Growth Factor Gene Polymorphisms with Susceptibility and Clinicopathologic Characteristics of Colorectal CancerJournal of Korean Medical Science, 2008
- Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with gastric cancerAnnals of Oncology, 2007
- A phase II study of oxaliplatin with low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX-4) as first line therapy for patients with advanced gastric cancerActa Oncologica, 2007
- Vascular endothelial growth factor: its prognostic, predictive, and therapeutic implicationsThe Lancet Oncology, 2001